US Edition
GPs to be paid to prescribe weight-loss jabs
NHS England will pay GPs up to £3,000 annually for prescribing Mounjaro to severely obese patients, funded by a £25 million pot to improve access and reduce private prescribing risks.
- Starting in April, GPs in England will be paid £3,000 a year to prescribe the weight-loss drug Mounjaro after the government added incentives to the GP contract.
- Incentive payments have previously been used in the GP contract to change GP behaviour, and ministers say these payments aim to ensure patients can access weight-loss support amid patchy rollout.
- GPs will also receive about £1,000 a year for referrals to weight-loss programmes, with incentives applying only to Mounjaro, which began prescribing this financial year.
19 Articles
19 Articles
GPs to be offered £3k bonuses to prescribe weight loss jabs from April 2026 - Birmingham Live
Access to Mounjaro is currently restricted to those who are severely obese with certain weight-related conditions. But Health Secretary Wes Streeting says he is determined that access to the drug is based on need rather than the ability to pay
The British government introduces more vaccines for doctors in an attempt to combat the increasingly increasing obesity among the population. The generalised medical offices in England should receive an average of 3,000...
NHS to Pay GPs to Prescribe Patients Weight Loss Jabs
Britain’s National Health Service (NHS) will start handling out monetary bonuses to GPs that prescribe weight loss jabs to patients as it moves to expedite the rollout of GLP-1 jabs nationally. The post NHS to Pay GPs to Prescribe Patients Weight Loss Jabs appeared first on Breitbart.
Coverage Details
Bias Distribution
- 53% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
